Acetylcysteine (Akorn, Inc.)
Welcome to the PulseAid listing for the Acetylcysteine drug offered from Akorn, Inc.. This Antidote [EPC],Antidote for Acetaminophen Overdose [EPC],Decreased Respiratory Secretion Viscosity [PE],Increased Glutathione Concentration [PE],Mucolytic [EPC],Reduction Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Akorn, Inc. |
NON-PROPRIETARY NAME: | Acetylcysteine |
SUBSTANCE NAME: | ACETYLCYSTEINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Antidote [EPC],Antidote for Acetaminophen Overdose [EPC],Decreased Respiratory Secretion Viscosity [PE],Increased Glutathione Concentration [PE],Mucolytic [EPC],Reduction Activity [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2015-03-25 |
END MARKETING DATE: | 0000-00-00 |
Acetylcysteine HUMAN PRESCRIPTION DRUG Details:
Item Description | Acetylcysteine from Akorn, Inc. |
LABELER NAME: | Akorn, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 200(mg/mL) |
START MARKETING DATE: | 2015-03-25 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 17478-660_73894a89-947a-458a-9b0f-172a25e60732 |
PRODUCT NDC: | 17478-660 |
APPLICATION NUMBER: | ANDA203173 |
Other ACETYLCYSTEINE Pharmaceutical Manufacturers / Labelers: